Ranbaxy announces retention of Giuliani's services

Ranbaxy Laboratories Ltd, the country’s largest pharmaceutical company, has clarified that it has retained the services of former New York City Mayor Rudy Giuliani and Giuliani Partners to provide advice and review compliance issues related to the recent United States Food and Drug Administration (USFDA) letters and Import Advisory, the company informed BSE .

In announcing the addition of Mayor Giuliani, Ranbaxy reiterated its commitment to work co-operatively with the FDA to address the Import Advisory and put into place measures which will allow its products identified on the Advisory to be released into the US marketplace.

As the FDA stated, all drugs manufactured by Ranbaxy have repeatedly tested safe and effective with no adverse incidents reported.

Ranbaxy is committed to a swift resolution to address these issues and to continuing to supply the global marketplace with safe and effective pharmaceuticals.

Ranbaxy is one of the world’s largest manufacturers of generic drugs, with production facilities in the US and India.